Download
s40364-021-00260-5.pdf 1,63MB
WeightNameValue
1000 Titel
  • p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors
1000 Autor/in
  1. Steurer, Stefan |
  2. Riemann, Claudia |
  3. Büscheck, Franziska |
  4. Luebke, Andreas M. |
  5. Kluth, Martina |
  6. Hube-Magg, Claudia |
  7. Hinsch, Andrea |
  8. Höflmayer, Doris |
  9. Weidemann, Sören |
  10. Fraune, Christoph |
  11. Möller, Katharina |
  12. Menz, Anne |
  13. Fisch, Margit |
  14. Rink, Michael |
  15. Bernreuther, Christian |
  16. Lebok, Patrick |
  17. Clauditz, Till S. |
  18. Sauter, Guido |
  19. Uhlig, Ria |
  20. Wilczak, Waldemar |
  21. Dum, David |
  22. Simon, Ronald |
  23. Minner, Sarah |
  24. Burandt, Eike |
  25. Krech, Rainer |
  26. Krech, Till |
  27. Marx, Andreas H. |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-01-25
1000 Erschienen in
1000 Quellenangabe
  • 9(1):7
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s40364-021-00260-5 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830855/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Tumor protein 63 (p63) is a transcription factor of the p53 gene family involved in differentiation of several tissues including squamous epithelium. p63 immunohistochemistry is broadly used for tumor classification but published data on its expression in cancer is conflicting.!##!Methods!#!To comprehensively catalogue p63 expression, tissue microarrays (TMAs) containing 12,620 tissue samples from 115 tumor entities and 76 normal tissue types were analyzed.!##!Results!#!p63 expression was seen in various normal tissues including squamous epithelium and urothelium. At least occasional weak p63 positivity could be detected in 61 (53%) of 115 different tumor types. The frequencies of p63 positivity was highest in squamous cell carcinomas irrespective of their origin (96-100%), thymic tumors (100%), urothelial carcinomas (81-100%), basal type tumors such as basal cell carcinomas (100%), and various salivary gland neoplasias (81-100%). As a rule, p63 was mostly expressed in cancers derived from p63 positive normal tissues and mostly not detectable in tumors derived from p63 negative cancers. However, exceptions from this rule occurred. A positive p63 immunostaining in cancers derived from p63 negative tissues was unrelated to aggressive phenotype in 422 pancreatic cancers, 160 endometrium cancers and 374 ovarian cancers and might be caused by aberrant squamous differentiation or represent stem cell properties. In 355 gastric cancers, aberrant p63 expression occurred in 4% and was linked to lymph node metastasis (p = 0.0208). Loss of p63 in urothelial carcinomas - derived from p63 positive urothelium - was significantly linked to advanced stage, high grade (p < 0.0001 each) and poor survival (p < 0.0001) and might reflect clinically relevant tumor dedifferentiation.!##!Conclusion!#!The high prevalence of p63 expression in specific tumor types makes p63 immunohistochemistry a suitable diagnostic tool. Loss of p63 expression might constitute a feature of aggressive cancers.
1000 Sacherschließung
lokal Cancer Research
lokal Research
lokal Biomedicine, general
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/U3RldXJlciwgU3RlZmFu|https://frl.publisso.de/adhoc/uri/UmllbWFubiwgQ2xhdWRpYQ==|https://frl.publisso.de/adhoc/uri/QsO8c2NoZWNrLCBGcmFuemlza2E=|https://frl.publisso.de/adhoc/uri/THVlYmtlLCBBbmRyZWFzIE0u|https://frl.publisso.de/adhoc/uri/S2x1dGgsIE1hcnRpbmE=|https://frl.publisso.de/adhoc/uri/SHViZS1NYWdnLCBDbGF1ZGlh|https://frl.publisso.de/adhoc/uri/SGluc2NoLCBBbmRyZWE=|https://frl.publisso.de/adhoc/uri/SMO2ZmxtYXllciwgRG9yaXM=|https://frl.publisso.de/adhoc/uri/V2VpZGVtYW5uLCBTw7ZyZW4=|https://frl.publisso.de/adhoc/uri/RnJhdW5lLCBDaHJpc3RvcGg=|https://frl.publisso.de/adhoc/uri/TcO2bGxlciwgS2F0aGFyaW5h|https://frl.publisso.de/adhoc/uri/TWVueiwgQW5uZQ==|https://frl.publisso.de/adhoc/uri/RmlzY2gsIE1hcmdpdA==|https://frl.publisso.de/adhoc/uri/UmluaywgTWljaGFlbA==|https://frl.publisso.de/adhoc/uri/QmVybnJldXRoZXIsIENocmlzdGlhbg==|https://frl.publisso.de/adhoc/uri/TGVib2ssIFBhdHJpY2s=|https://frl.publisso.de/adhoc/uri/Q2xhdWRpdHosIFRpbGwgUy4=|https://frl.publisso.de/adhoc/uri/U2F1dGVyLCBHdWlkbw==|https://frl.publisso.de/adhoc/uri/VWhsaWcsIFJpYQ==|https://frl.publisso.de/adhoc/uri/V2lsY3phaywgV2FsZGVtYXI=|https://frl.publisso.de/adhoc/uri/RHVtLCBEYXZpZA==|https://orcid.org/0000-0003-0158-4258|https://frl.publisso.de/adhoc/uri/TWlubmVyLCBTYXJhaA==|https://frl.publisso.de/adhoc/uri/QnVyYW5kdCwgRWlrZQ==|https://frl.publisso.de/adhoc/uri/S3JlY2gsIFJhaW5lcg==|https://frl.publisso.de/adhoc/uri/S3JlY2gsIFRpbGw=|https://frl.publisso.de/adhoc/uri/TWFyeCwgQW5kcmVhcyBILg==
1000 Hinweis
  • DeepGreen-ID: 24c18401024a4f40b70d7151bbf8a8f5 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6464445.rdf
1000 Erstellt am 2023-11-16T03:48:36.123+0100
1000 Erstellt von 322
1000 beschreibt frl:6464445
1000 Zuletzt bearbeitet 2023-11-30T23:55:35.553+0100
1000 Objekt bearb. Thu Nov 30 23:55:35 CET 2023
1000 Vgl. frl:6464445
1000 Oai Id
  1. oai:frl.publisso.de:frl:6464445 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source